Download your free eBook: Accelerating Dengue research with the highest quality proteins and antibodies 

The dengue virus poses a significant risk to global health and there is currently no vaccine or specific treatment available for those infected.

A major challenge faced by academic researchers, drug developers and public health scientists is Dengue’s close structural similarity to the Zika virus – which continues to hamper research efforts, requiring more sensitive diagnostic tools to differentiate between them.

In this eBook, we discuss:

• The challenges to preventing the proliferation of DENV across the globe.
• The key DENV proteins used in the research and development of vaccines, diagnostics and therapeutics.
• Overcoming some of the major challenges in DENV research.
• The advantages of using the highest quality recombinant DENV proteins and antibodies.

Simply fill out the form below to get your copy.